Figure 2.
Hamilton Anxiety Rating Scale scores (Mean±SD) in major depressed patients who went on a clinical trial sertraline (50-100 mg/day) + placebo, versus sertraline (50-100 mg/day) + celecoxib (200 mg/day).
* p-value ≤ 0.05, **p-value ≤ 0.01, ***p-value ≤ 0.001, p-values show significant improvement of HAMA scores during course of treatment in each group.
† p-value ≤ 0.05, Pvalue shows between group differences in HAMA scores during course of treatment.